Reclazepam |
| Clinical data |
|---|
| ATC code | |
|---|
| Identifiers |
|---|
IUPAC name 2-[7-chloro-5-(2-chlorophenyl)-2,3-dihydro-1,4-benzodiazepin-1-yl]-1,3-oxazol-4-one
|
| CAS Number | |
|---|
| PubChem CID | |
|---|
| ChemSpider | |
|---|
| UNII | |
|---|
| KEGG | |
|---|
| CompTox Dashboard (EPA) | |
|---|
| Chemical and physical data |
|---|
| Formula | C18H13Cl2N3O2 |
|---|
| Molar mass | 374.22 g·mol−1 |
|---|
| 3D model (JSmol) | |
|---|
SMILES Clc1ccccc1/C4=N/CCN(C\2=N\C(=O)CO/2)c3ccc(Cl)cc34
|
InChI=1S/C18H13Cl2N3O2/c19-11-5-6-15-13(9-11)17(12-3-1-2-4-14(12)20)21-7-8-23(15)18-22-16(24)10-25-18/h1-6,9H,7-8,10H2  Key:MQGIGGJUPITZSE-UHFFFAOYSA-N
|
| (verify) |
Reclazepam[1] is a drug which is a benzodiazepine derivative. It has sedative and anxiolytic effects similar to those produced by other benzodiazepine derivatives, and has a short duration of action.[2]
See also
References
- ^ US Patent 4208327
- ^ Pscyhotropics.dk (20 January 1986). "reclazepam". Retrieved 24 August 2009.
This article is copied from an
article on Wikipedia® - the free encyclopedia created and edited by its online user community. The text was not checked or edited by anyone on our staff. Although the vast majority of Wikipedia® encyclopedia articles provide accurate and timely information, please do not assume the accuracy of any particular article. This article is distributed under the terms of
GNU Free Documentation License.
All content on this website, including dictionary, thesaurus, literature, geography, and other reference data is for informational purposes only. This information should not be considered complete, up to date, and is not intended to be used in place of a visit, consultation, or advice of a legal, medical, or any other professional.
)
